RNA-seq analysis indicated that in response to cytokines, RelB overwhelmingly activates genes in GBM, and the enriched pathways are involved in proinflammatory responses (p = 1.37 × 10−7), perpetuating inflammation, and inflammatory cell chemotaxis (Fig. 3e). The gene discussed is RELB; the disease is glioblastoma.